Clinical Trials Browser

Leflunomide × Breast × 1 year × Clear all

NCT03709446 2026-03-19

Leflunomide in Previously Treated Metastatic Triple Negative Cancers

Phase 1/2 Completed

Breast Diseases, Breast Neoplasms, Triple Negative Breast Neoplasms

NCT04997993 2025-06-25

Leflunomide in Patients With PTEN-Altered Advanced Solid Malignancies and HER2 Negative Breast Cancer

Phase 1 Recruiting

BreastOther solid neoplasm

PTEN-Altered Advanced Solid Tumors and HER2 Negative Breast Cancer